Alzheimer’s disease destroys brain cells, progressively stripping away memory, thinking ability, and eventually the capacity to carry out even basic daily tasks like eating and getting dressed. It is the most common cause of dementia, affecting over 55 million people worldwide, with that number expected to reach 139 million by 2050. The damage begins years before symptoms appear, and once it starts, it follows a fairly predictable path through the brain.
How Alzheimer’s Damages the Brain
Two types of abnormal proteins drive the disease. The first, called amyloid beta, clumps together into sticky plaques that build up between brain cells. These plaques cluster near the junctions where neurons communicate with each other, disrupting the signals that form the basis of thought and memory. The second protein, called tau, normally helps maintain the internal scaffolding that gives neurons their shape and allows nutrients to travel through them. In Alzheimer’s, tau becomes defective, detaches from that scaffolding, and tangles into knots inside the cell. These tangles block the transport of nutrients and chemicals within the neuron, essentially starving it from the inside.
Amyloid plaques and tau tangles don’t just cause damage independently. They work together, amplifying each other’s effects on the connections between brain cells. As these proteins accumulate, the brain’s immune cells (called microglia) activate in response. In a healthy brain, these cells clean up debris and fight infection. In Alzheimer’s, they become chronically inflamed, and that sustained inflammation adds another layer of damage to surrounding tissue.
The disease also depletes key chemical messengers. Acetylcholine, a neurotransmitter essential for processing memory and learning, drops in both concentration and function. At the same time, another messenger called glutamate starts overstimulating neurons. Healthy brains carefully regulate glutamate levels, but in Alzheimer’s, the cleanup system fails, leaving neurons exposed to a slow, toxic level of activation that contributes to cell death.
Where the Damage Starts
Alzheimer’s doesn’t attack the whole brain at once. It begins in the hippocampus, a small, curved structure deep in the brain that is essential for forming and organizing new memories. Specific subregions of the hippocampus, particularly an area called CA1 and the subiculum, begin shrinking years before a person shows noticeable symptoms. This early, targeted damage is why difficulty forming new memories is almost always the first sign of the disease.
As the disease progresses, damage spreads outward to regions that control language, reasoning, sensory processing, and emotional regulation. Eventually, plaques and tangles reach virtually every part of the brain, and the overall volume of brain tissue shrinks significantly.
What Each Stage Looks and Feels Like
Alzheimer’s is often described in three broad stages, though the boundaries between them blur in real life.
In the mild stage, the most common problems are memory lapses that go beyond normal forgetfulness. A person might get lost on a familiar route, have trouble managing money or paying bills, repeat the same questions, or take noticeably longer to finish routine tasks. Personality shifts can appear here too, such as increased irritability or withdrawal from social activities. This is the stage when most people receive a diagnosis.
In the moderate stage, the damage reaches brain areas responsible for language, logical thinking, and sensory processing. People may struggle to recognize family members and friends. Learning new information becomes extremely difficult. Multistep tasks that once felt automatic, like getting dressed in the right order, become confusing. Hallucinations, delusions, paranoia, and impulsive behavior can emerge during this stage, which is often the longest and most challenging for caregivers.
In the severe stage, communication is largely lost. The person becomes completely dependent on others for all care. Near the end of life, they may be in bed most or all of the time as the body’s systems gradually shut down.
Behavioral and Emotional Changes
Memory loss gets the most attention, but Alzheimer’s changes behavior and personality in ways that can be just as disruptive. Up to 97% of people living with the disease develop some form of behavioral or psychological symptoms. Depression and apathy are the most common. About a third of people experience delusions, agitation, or repetitive physical behaviors like pacing, fidgeting, or wandering.
Sleep disturbances are frequent and particularly hard on both the person with Alzheimer’s and anyone living with them. A disrupted body clock can cause nighttime restlessness and daytime drowsiness, sometimes reversing the normal sleep-wake cycle entirely. Verbal symptoms, including repeated calling out, yelling, or asking the same question over and over, are also common and tend not to respond well to medication. Changes in appetite, either eating much more or losing interest in food, add another layer of difficulty to daily care.
How It Affects Daily Life
The practical impact of Alzheimer’s on everyday routines is enormous and grows steadily over time. Early on, a person may just need gentle reminders to bathe or take medication. They might forget appointments, leave the stove on, or struggle with tasks that require planning, like cooking a meal or following a recipe they’ve made for decades.
As the disease advances, personal care becomes increasingly difficult. Getting dressed might mean putting clothes on in the wrong order or choosing inappropriate clothing for the weather. Eating can become complicated: a person may forget to chew or swallow, lose the ability to use utensils, or simply not recognize food. In the later stages, bathing, toileting, and all other basic self-care require full assistance from another person.
How Alzheimer’s Is Diagnosed
Diagnosis has traditionally relied on cognitive testing, brain imaging, and ruling out other causes of memory loss. More recently, blood-based biomarker tests have entered clinical practice. These tests measure specific forms of tau and amyloid proteins in the blood and can help confirm or rule out Alzheimer’s pathology in people who are already showing cognitive symptoms. A negative result on a high-quality blood test can rule out Alzheimer’s with high probability, while a positive result is typically confirmed with a spinal fluid test or a specialized brain scan. These blood tests are currently recommended only for people with measurable cognitive impairment who are being evaluated in specialized memory clinics, not as screening tools for the general population.
Current Treatment Options
No treatment cures Alzheimer’s or fully stops its progression. The most established medications work by boosting the brain’s remaining supply of acetylcholine or by regulating glutamate activity, which can modestly improve symptoms or slow their worsening for a period of time.
A newer class of treatments targets amyloid plaques directly, aiming to clear them from the brain. Clinical trials have shown these drugs consistently reduce amyloid buildup, but the connection between clearing plaques and meaningful improvement in daily thinking and functioning has been inconsistent. Out of ten trials that measured amyloid reduction, only four showed significant cognitive benefits. These treatments also carry a risk of brain swelling or small brain bleeds, particularly for people who carry a specific genetic variant linked to higher Alzheimer’s risk. For now, they represent a cautious step forward rather than a breakthrough, and the decision to use them involves weighing modest potential benefits against real side effects.